Moreover, somatic point mutation data showed that, in the TCGA cohort, only three breast cancer patients out of 977 harbored at least one GJA1 mutation, accounting for 0.31% of the tumors (Figure 3e). This evidence concerns the gene GJA1 and breast cancer.